Kineta Inc
NASDAQ:KA 3:59:50 PM EDT
| Market Cap (Intraday) | 22.47M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $2.19 |
| 50-Day MA | $2.11 |
| 200-Day MA | $3.97 |
Kineta Inc Stock, NASDAQ:KA
219 Terry Avenue North, Suite 300, Seattle, Washington 98109
United States of America
Phone: +1.206.378.0400
Number of Employees: 11
Description
Kineta, Inc. is a clinical-stage biotechnology company, which develops immunotherapies for cancer patients. Its immuno-oncology focused platform aims at developing fully human antibodies to address the major mechanisms of cancer immune resistance. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA.